Jens Juul Holst

Jens Juul Holst

Professor


  1. 2004
  2. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.

    Holst, Jens Juul & Deacon, Carolyn F., 2004, In: Current Opinion in Pharmacology. 4, 6, p. 589-96 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Glucagon-like peptide- 1 secretion is influenced by perfusate glucose concentration and a feedback mechanism involving somatostatin in isolated perfused porcine ileum

    Hansen, L., Hartmann, B., Mineo, H. & Holst, Jens Juul, 2004, In: Regul. Pept.. 118, p. 11-18

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glucagon-like peptide-2 (GLP-2) inhibits gastric emptying and promotes satiety in man, but is not as potent as Glucagon-like peptide-1 (GLP-1)

    Nagell, C. F., Wettergren, A., Fog Pedersen, J., Mortensen, D. & Holst, Jens Juul, 2004, In: Scandinavian Journal of Gastroenterology. 39, p. 353-358

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glycemia and insulinemia in healthy subjects after lactose equivalent meals of milk and other food proteins: on the role of plasma amino acids and incretins

    Nilsson, M., Stenberg, M., Frid, A. H., Holst, Jens Juul & Björck, I., 2004, In: Am. J. Clin. Nutr.. 80, p. 1246-1253

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Incretins, insulin secretion and type 2 diabetes mellitus

    Vilsboll, T. & Holst, Jens Juul, 2004, In: Diabetologia. 47, p. 654-662

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Inhibitors of dipeptidyl peptidase IV: a novel approach for the prevention and treatment of Type 2 diabetes?

    Deacon, Carolyn F., Ahrén, B. & Holst, Jens Juul, 2004, In: Expert Opinion on Investigational Drugs. 13, 9, p. 1091-102 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Insulin secretion and incretin hormones after oral glucose in impaired glucose tolerance

    Rask, E., Olsson, T., Söderberg, S., Holst, Jens Juul, Tura, A., Pacini, G. & Ahren, B., 2004, In: Metabolism. 53, p. 624-631

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of beta-cells.

    Haugaard, S. B., Andersen, Ove, Storgaard, H., Dela, Flemming, Holst, Jens Juul, Iversen, J., Nielsen, J. O. & Madsbad, Sten, 2004, In: American Journal of Physiology: Endocrinology and Metabolism. 287, 4, p. E677-85 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Intravenous glucagon-like peptide 1 (GLP-1) normalizes blood glucose after major surgery in patients with type 2 diabetes

    Meier, J. J., Weyhe, D., Michaely, M., Senkal, M., Zumtobel, V., Nauck, M. A., Holst, Jens Juul, Schmidt, W. E. & Gallwitz, B., 2004, In: Critical Care Medicine. 32, p. 848-851

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Milrinone efficiently potentiates insulin secretion induced by orally but not intravenously administered glucose in C57BL6J mice

    Degerman, E., Manganiello, V., Holst, Jens Juul & Ahren, B., 2004, In: Eur. J. Pharmacol.. 498, p. 319-323

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207